Literature DB >> 19103644

Protein kinase C-dependent alpha-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin II-B.

Francesca Argellati1, Cinzia Domenicotti, Mario Passalacqua, Elzbieta Janda, Edon Melloni, Umberto M Marinari, Maria A Pronzato, Roberta Ricciarelli.   

Abstract

A substantial body of evidence indicates that protein kinase C (PKC) is involved in the alpha-secretory processing of the amyloid precursor protein (APP), an event that reduces the formation of the pathogenic amyloid-beta peptide. Recently, we have shown that trafficking and processing of APP are both impaired by knockdown of myosin II-B, one of the major neuronal motor proteins. Here, we provide evidence that the alpha-secretory processing of APP is mediated by PKC-dependent phosphorylation of myosin II-B. This signaling pathway provides an important link between APP and the neuronal cytoskeleton and might be crucial for the understanding of the biological and pathological roles of APP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103644     DOI: 10.1096/fj.08-119263

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  3 in total

1.  Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.

Authors:  Claudia H Huichalaf; Ismael Al-Ramahi; Kyung-Won Park; Stacy D Grunke; Nan Lu; Maria de Haro; Karla El-Zein; Tatiana Gallego-Flores; Alma M Perez; Sung Yun Jung; Juan Botas; Huda Y Zoghbi; Joanna L Jankowsky
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

2.  Integrating the Alzheimer's disease proteome and transcriptome: a comprehensive network model of a complex disease.

Authors:  Peter Hallock; Michael A Thomas
Journal:  OMICS       Date:  2012 Jan-Feb

Review 3.  Non-Muscle Myosin II in Axonal Cell Biology: From the Growth Cone to the Axon Initial Segment.

Authors:  Ana Rita Costa; Monica M Sousa
Journal:  Cells       Date:  2020-08-26       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.